These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31851087)

  • 1. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn's disease treated with antitumor necrosis factor-alpha agents based on Parks' classification.
    Azzam N; Alharbi O; Almadi M; Aljebreen A; AlAmeel T; Alabbas M; Bahammam S; Bashmail A; Alomar Y; Mosli M
    Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):187-192. PubMed ID: 31851087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
    Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.
    Singh A; Kakkar C; Garg S; Arora K; Midha V; Mahajan R; Virk SS; Jain NP; Singh D; Sood K; Tripathi A; Gupta D; Kaushal IG; Galhotra RD; Saggar K; Sood A
    Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K; Cheifetz AS
    World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
    Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease.
    Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S
    World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
    De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1306-1314. PubMed ID: 34389484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    Cao D; Qian K; Zhao Y; Hong J; Chen H; Wang X; Yang N; Zhang C; Cao J; Jia K; Wu G; Zhu M; Shen J; Zhang Y; Cui Z; Wang Z
    J Crohns Colitis; 2023 Apr; 17(4):580-592. PubMed ID: 36322703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?
    Rinawi F; Greer MC; Walters T; Church PC; Ricciuto A; Langer JC; Griffiths AM
    J Pediatr Surg; 2022 Nov; 57(11):569-574. PubMed ID: 35491271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab and surgical treatment of complex anal Crohn's disease.
    Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ
    Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
    Tandon P; Rhee GG; Schwartz D; McCurdy JD
    Dig Dis Sci; 2019 Nov; 64(11):3066-3077. PubMed ID: 31030304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn's disease: a cross-sectional study.
    Miranda EF; Nones RB; Baraúna FB; de Nardi Marçal G; Olandoski M; de Moraes TP; Kotze PG
    Tech Coloproctol; 2024 Jul; 28(1):86. PubMed ID: 39031218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
    Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn's disease.
    Chambaz M; Verdalle-Cazes M; Desprez C; Thomassin L; Charpentier C; Grigioni S; Armengol-Debeir L; Bridoux V; Savoye G; Savoye-Collet C
    Dig Liver Dis; 2019 Mar; 51(3):358-363. PubMed ID: 30612820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.
    Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR
    Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.